A Randomised, Double Blind Study to Evaluate the Safety and Efficacy of the p38 Kinase Inhibitor, GW856553, in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy.
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs Losmapimod (Primary)
- Indications Neuropathic pain
- Focus Pharmacogenomic; Therapeutic Use
- 10 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2010 New trial record